Vimarsana
Biggest News Aggregation in the World

Page 5 - Breakthrough Device Designations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Device Designations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Device Designations Today - Breaking & Trending Today

ONWARD® to Participate in Degroof Petercam Healthcare - Vimarsana News

ONWARD® to Participate in Degroof Petercam Healthcare

CEO Dave Marver will provide update on the Company’s progress toward launch of its first therapy later this year...

ONWARD® Announces Start of HemON NL Clinical Study - Vimarsana News

ONWARD® Announces Start of HemON NL Clinical Study

HemON NL is evaluating the use of ARC-IM® Therapy to address hemodynamic instability after spinal cord injury EINDHOVEN, the Netherlands, Jan. 18, 2024 -- ONWARD Medical N.V. , the medical...

Global In Vitro Diagnostics Market to Reach $138.4 Billion, Globally by 2032: Allied Market Research - Vimarsana News

Global In Vitro Diagnostics Market to Reach $138.4 Billion, Globally by 2032: Allied Market Research

The global in vitro diagnostics market is expanding rapidly due to a surge in the number of diagnostic laboratories, rise in awareness regarding personalized medicine and early disease diagnosis, and growing prevalence of infectious and chronic diseases.Wilmington, Delaware, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "In Vitro Diagnostics Market by Product and Services (Reagents and Kits, Instruments, Software, and Services), Technique, (Immunodiagnostic

Source: yahoo.com
Nature Medicine Publication Highlights Potential for ONWARD® ARC Therapy™ to Improve Mobility After Parkinson's Disease - Vimarsana News

Nature Medicine Publication Highlights Potential for ONWARD® ARC Therapy™ to Improve Mobility After Parkinson's Disease

Therapy to be supported by newly awarded $1M grant from Michael J. Fox FoundationEINDHOVEN, the Netherlands, Nov. 06, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces a publication in Nature Medicine using investigational ONWARD ARC Therapy to address gait challenges related to Parkinson’s disea

Source: yahoo.com
Nature Medicine Publication Highlights Potential for ONWARD® ARC Therapy™ to Improve Mobility After Parkinson's Disease - Vimarsana News

Nature Medicine Publication Highlights Potential for ONWARD® ARC Therapy™ to Improve Mobility After Parkinson's Disease

EINDHOVEN, the Netherlands, Nov. 06, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function,